title: The hazards of cross comparing the drug toxicity results from different trials in metastatic renal cancer: in response to a letter from Dr. Catalá-López.
authors.forename: Thomas
authors.initials: T
authors.lastname: Powles
authors.forename: Naveed
authors.initials: N
authors.lastname: Sarwar
authors.forename: Rob
authors.initials: R
authors.lastname: Jones
authors.forename: Peter
authors.initials: P
authors.lastname: Wilson
authors.forename: Ekaterina
authors.initials: E
authors.lastname: Boleti
authors.forename: Andrew
authors.initials: A
authors.lastname: Protheroe
authors.forename: Simon
authors.initials: S
authors.lastname: Crabb
authors.forename: Jonathan
authors.initials: J
authors.lastname: Shamash
authors.forename: Andrew
authors.initials: A
authors.lastname: Stockdale
authors.forename: Louise
authors.initials: L
authors.lastname: Lim
authors.forename: Paul
authors.initials: P
authors.lastname: Nathan
authors.forename: Simon
authors.initials: S
authors.lastname: Chowdury
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011743:Pyrimidines; D011758:Pyrroles; D013449:Sulfonamides